• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙类风湿关节炎的患病率。

The prevalence of rheumatoid arthritis in Spain.

机构信息

Rheumatology Department, Complexo Hospitalario Universitario de A Coruña, As Xubias 84, 15006, A Coruña, Spain.

Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain.

出版信息

Sci Rep. 2020 Dec 9;10(1):21551. doi: 10.1038/s41598-020-76511-6.

DOI:10.1038/s41598-020-76511-6
PMID:33299019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7725786/
Abstract

Rheumatoid arthritis (RA) prevalence is believed to be around 1% worldwide, although it varies considerably among different populations. The aim of EPISER2016 study was to estimate the prevalence of RA in the general adult population in Spain. We designed a population-based cross-sectional study. A national survey was conducted between November 2016 and October 2017 involving a probabilistic sample from the general population aged 20 years or older. Subjects were randomly selected for phone screening using a computer-assisted telephone interviewer system. Positive RA screening results were evaluated by a rheumatologist. Cases fulfilled the 1987 ACR and/or the 2010 ACR/EULAR criteria; previous diagnosis established by a rheumatologist and clearly identified in medical records were also accepted regardless of the criteria used. Prevalence estimates with 95% CI were calculated taking into account the design of the sample (weighting based on age, sex, and geographic origin using as a reference the distribution of the population in Spain). 4916 subjects participated in the study and 39 RA cases were confirmed. RA estimated prevalence was 0.82% (95% CI 0.59-1.15). Mean age of RA cases was 60.48 (14.85) years, they were more frequently women (61.5%), from urban areas (74.4%), non-smokers (43.6%), and with a high body mass index (53.8% with overweight). Extrapolating to the population in Spain (approximately 37 million are ≥ 20 years old), it was estimated that there were between 220,000 and 430,000 people aged 20 years or older with RA. No undiagnosed cases were detected, which could be related to the establishment of early arthritis clinics around the country, increasing the rates of diagnosis during early phases of RA.

摘要

类风湿关节炎(RA)的全球患病率约为 1%,但在不同人群中差异很大。EPISER2016 研究的目的是估计西班牙普通成年人群中 RA 的患病率。我们设计了一项基于人群的横断面研究。这项全国性调查于 2016 年 11 月至 2017 年 10 月期间进行,涉及年龄在 20 岁及以上的普通人群的概率抽样。采用计算机辅助电话访谈系统对受试者进行随机电话筛选。阳性 RA 筛查结果由风湿病学家进行评估。病例符合 1987 年 ACR 和/或 2010 年 ACR/EULAR 标准;以前由风湿病学家诊断并在病历中明确记录的病例也被接受,无论使用何种标准。考虑到样本设计(根据年龄、性别和地理来源进行加权,以西班牙人口分布为参考),计算了具有 95%CI 的患病率估计值。4916 名受试者参加了研究,确诊了 39 例 RA。RA 的估计患病率为 0.82%(95%CI 0.59-1.15)。RA 病例的平均年龄为 60.48(14.85)岁,他们更多是女性(61.5%),来自城市地区(74.4%),不吸烟(43.6%),且体重指数较高(53.8%超重)。外推至西班牙人口(约 3700 万人年龄在 20 岁及以上),估计有 22 万至 43 万人年龄在 20 岁及以上患有 RA。未发现未确诊病例,这可能与全国关节炎早期诊所的建立有关,这增加了 RA 早期阶段的诊断率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0919/7725786/4661bf7ec51b/41598_2020_76511_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0919/7725786/4661bf7ec51b/41598_2020_76511_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0919/7725786/4661bf7ec51b/41598_2020_76511_Fig1_HTML.jpg

相似文献

1
The prevalence of rheumatoid arthritis in Spain.西班牙类风湿关节炎的患病率。
Sci Rep. 2020 Dec 9;10(1):21551. doi: 10.1038/s41598-020-76511-6.
2
The prevalence of rheumatoid arthritis in the general population of Spain.西班牙普通人群中类风湿关节炎的患病率。
Rheumatology (Oxford). 2002 Jan;41(1):88-95. doi: 10.1093/rheumatology/41.1.88.
3
Prevalence of rheumatoid arthritis in Serbia.塞尔维亚类风湿关节炎的患病率。
Rheumatol Int. 2014 May;34(5):649-58. doi: 10.1007/s00296-013-2897-7. Epub 2013 Nov 29.
4
The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry.西班牙类风湿关节炎的发病率:来自全国基层医疗登记处的结果。
Rheumatology (Oxford). 2008 Jul;47(7):1088-92. doi: 10.1093/rheumatology/ken205. Epub 2008 May 29.
5
Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases.西班牙成年普通人群中痛风的患病率:估算未确诊病例的比例。
Joint Bone Spine. 2022 Jan;89(1):105257. doi: 10.1016/j.jbspin.2021.105257. Epub 2021 Jul 26.
6
Prevalence and management of rheumatoid arthritis in the general population of Greece--the ESORDIG study.希腊普通人群中类风湿关节炎的患病率及管理——ESORDIG研究
Rheumatology (Oxford). 2006 Dec;45(12):1549-54. doi: 10.1093/rheumatology/kel140. Epub 2006 May 11.
7
Prevalence of ankylosing spondylitis in Spain: EPISER2016 Study.西班牙强直性脊柱炎患病率:EPISER2016 研究。
Scand J Rheumatol. 2020 May;49(3):210-213. doi: 10.1080/03009742.2019.1669704. Epub 2019 Nov 4.
8
The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey.土耳其伊兹密尔城市人口中类风湿关节炎的患病率。
Clin Exp Rheumatol. 2004 Jul-Aug;22(4):416-20.
9
Prevalence of rheumatoid arthritis in Antalya, Turkey.土耳其安塔利亚类风湿关节炎的患病率。
Clin Rheumatol. 2005 Jun;24(3):212-4. doi: 10.1007/s10067-004-1006-4. Epub 2004 Nov 13.
10
Prevalence of rheumatoid arthritis in Tucumán, Argentina.阿根廷图库曼类风湿关节炎的患病率。
J Rheumatol. 2002 Jun;29(6):1166-70.

引用本文的文献

1
Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain.生物类似药与参比生物药治疗类风湿关节炎:西班牙加泰罗尼亚的一项多中心横断面研究
Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07568-9.
2
Incidence and prevalence of rheumatoid arthritis in Thailand based on National administrative health data and a comprehensive literature review.基于国家行政卫生数据和全面文献综述的泰国类风湿关节炎发病率和患病率
Sci Rep. 2025 Jul 1;15(1):20665. doi: 10.1038/s41598-025-07376-w.
3
Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry.

本文引用的文献

1
Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017.全球、地区和国家类风湿关节炎负担 1990-2017 年:2017 年全球疾病负担研究的系统分析。
Ann Rheum Dis. 2019 Nov;78(11):1463-1471. doi: 10.1136/annrheumdis-2019-215920. Epub 2019 Sep 11.
2
Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system.在一个综合医疗服务提供系统中,类风湿关节炎的发病率和患病率的长期变化趋势。
Rheumatol Int. 2019 Mar;39(3):541-549. doi: 10.1007/s00296-018-04235-y. Epub 2019 Jan 17.
3
初治类风湿关节炎患者使用生物制剂和靶向合成药物的临床及处方特征的性别差异:来自BIOBADASER III注册研究的数据
Arthritis Res Ther. 2025 May 14;27(1):103. doi: 10.1186/s13075-025-03571-2.
4
Real-World Evidence for Baricitinib in the Treatment of Rheumatoid Arthritis in Spain: A Systematic Literature Review.巴瑞替尼治疗西班牙类风湿关节炎的真实世界证据:一项系统文献综述
Adv Ther. 2025 May;42(5):2403-2428. doi: 10.1007/s12325-025-03161-3. Epub 2025 Mar 22.
5
Association between triglyceride levels and rheumatoid arthritis prevalence in women: a cross-sectional study of NHANES (1999-2018).女性甘油三酯水平与类风湿关节炎患病率之间的关联:一项对美国国家健康与营养检查调查(1999 - 2018年)的横断面研究
BMC Womens Health. 2025 Mar 21;25(1):129. doi: 10.1186/s12905-025-03645-y.
6
Predictive factors of methotrexate monotherapy success in patients with rheumatoid arthritis in a national referral center: a cohort study.在一家国家级转诊中心,类风湿关节炎患者甲氨蝶呤单药治疗成功的预测因素:一项队列研究
BMC Rheumatol. 2024 Sep 12;8(1):42. doi: 10.1186/s41927-024-00412-8.
7
Enkephalins and Pain Modulation: Mechanisms of Action and Therapeutic Perspectives.脑啡肽和疼痛调制:作用机制和治疗前景。
Biomolecules. 2024 Jul 30;14(8):926. doi: 10.3390/biom14080926.
8
Rheumatoid arthritis epidemiology: a nationwide study in Poland.类风湿关节炎的流行病学:波兰全国性研究。
Rheumatol Int. 2024 Jun;44(6):1155-1163. doi: 10.1007/s00296-024-05591-8. Epub 2024 Apr 27.
9
Autoimmune findings in patients with silicosis in Spain.西班牙矽肺病患者的自身免疫性表现
Drugs Context. 2024 Feb 27;13. doi: 10.7573/dic.2023-11-1. eCollection 2024.
10
Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning.使用非结构化医疗保健数据和机器学习技术评估类风湿关节炎合并间质性肺疾病患者的患病率和临床特征。
RMD Open. 2024 Jan 30;10(1):e003353. doi: 10.1136/rmdopen-2023-003353.
Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study.
加拿大魁北克省类风湿关节炎的患病率、发病率和死亡率的时间趋势:一项基于人群的研究。
Clin Rheumatol. 2017 Dec;36(12):2667-2671. doi: 10.1007/s10067-017-3796-1. Epub 2017 Aug 21.
4
Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology.西班牙成年人群体中风湿性疾病的患病率(EPISER 2016研究):目标与方法
Reumatol Clin (Engl Ed). 2019 Mar-Apr;15(2):90-96. doi: 10.1016/j.reuma.2017.06.009. Epub 2017 Jul 31.
5
Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.2004-2014 年美国医疗保健索赔数据库中成年人群类风湿关节炎的流行率。
Rheumatol Int. 2017 Sep;37(9):1551-1557. doi: 10.1007/s00296-017-3726-1. Epub 2017 Apr 28.
6
Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: A systematic literature review.类风湿关节炎发病率、患病率及严重程度的时间趋势:一项系统文献综述
Joint Bone Spine. 2016 Dec;83(6):625-630. doi: 10.1016/j.jbspin.2016.07.007. Epub 2016 Sep 5.
7
[Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].[基于健康保险数据的德国类风湿性关节炎患病率:地区差异及PROCLAIR研究的初步结果]
Z Rheumatol. 2016 Oct;75(8):819-827. doi: 10.1007/s00393-016-0088-0.
8
Rheumatoid arthritis prevalence in Quebec.魁北克类风湿性关节炎的患病率。
BMC Res Notes. 2014 Dec 19;7:937. doi: 10.1186/1756-0500-7-937.
9
Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.在临床实践中,哪些因素会影响使用肿瘤坏死因子抑制剂治疗期间的影像学进展?来自丹麦全国性DANBIO注册中心930例类风湿性关节炎患者的结果。
J Rheumatol. 2014 Dec;41(12):2352-60. doi: 10.3899/jrheum.131299. Epub 2014 Oct 1.
10
Prevalence and incidence of rheumatoid arthritis in Italy.意大利类风湿关节炎的患病率和发病率。
Rheumatol Int. 2014 May;34(5):659-64. doi: 10.1007/s00296-014-2974-6. Epub 2014 Mar 9.